Genetic variations of CAV1 gene contribute to HCC risk: a case–control study

[1]  Wen-Shin Chang,et al.  Association of caveolin-1 genotypes with gastric cancer in Taiwan. , 2014, Anticancer research.

[2]  J. Long,et al.  Astrocyte elevated gene-1 is a novel biomarker of epithelial–mesenchymal transition and progression of hepatocellular carcinoma in two China regions , 2014, Tumor Biology.

[3]  P. Song.  Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines. , 2013, Bioscience trends.

[4]  Min Liu,et al.  Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1–related Hepatocellular Carcinoma , 2013, Epidemiology.

[5]  F. Sotgia,et al.  Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation. , 2013, The American journal of pathology.

[6]  Y. Kuroda,et al.  Functional polymorphism in the CAV1 T29107A gene and its association with prostate cancer risk among Japanese men. , 2013, Anticancer research.

[7]  D. Massi,et al.  Caveolin-1 as a promoter of tumour spreading: when, how, where and why , 2013, Journal of cellular and molecular medicine.

[8]  L. Jeng,et al.  The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma. , 2013, Anticancer research.

[9]  J. Zucman‐Rossi,et al.  Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. , 2012, Journal of hepatology.

[10]  R. Ádány,et al.  Prognostic relevance of the expressions of CAV1 and TES genes on 7q31 in melanoma. , 2012, Frontiers in bioscience.

[11]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[12]  S. Chi,et al.  Caveolin-1 Is Associated with VCAM-1 Dependent Adhesion of Gastric Cancer Cells to Endothelial Cells , 2006, Cellular Physiology and Biochemistry.

[13]  Robin L. Anderson,et al.  Caveolin-1 inhibits breast cancer growth and metastasis , 2004, Oncogene.

[14]  J. Couet,et al.  Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells , 2004, Cancer biology & therapy.

[15]  J. Minna,et al.  Different Roles for Caveolin-1 in the Development of Non-Small Cell Lung Cancer versus Small Cell Lung Cancer , 2004, Cancer Research.

[16]  C. Rao,et al.  Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. , 2004, Oncology reports.

[17]  T. Thompson.  Metastasis-related Genes in Prostate Cancer: The Role of Caveolin-1 , 1998, Cancer and Metastasis Reviews.

[18]  H. Doihara,et al.  Caveolin-1 as Tumor Suppressor Gene in Breast Cancer , 2003, Surgery Today.

[19]  T. Wheeler,et al.  The role of caveolin-1 in androgen insensitive prostate cancer. , 2002, The Journal of urology.

[20]  M Dietel,et al.  Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. , 2001, The American journal of pathology.

[21]  M. Robinson,et al.  Caveolin-1 expression is associated with high-grade bladder cancer. , 2001, Urology.

[22]  T Hayakawa,et al.  Invasion activating caveolin-1 mutation in human scirrhous breast cancers. , 2001, Cancer research.

[23]  J. Engelman,et al.  Genes encoding human caveolin‐1 and ‐2 are co‐localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers , 1998, FEBS letters.

[24]  Richard G. W. Anderson,et al.  Caveolin, a protein component of caveolae membrane coats , 1992, Cell.